ASNS and neoplasm: Similar to our initial xenograft in female mice only (tumorigenicity study 1), tumor volume was significantly different between the HCT116 ASNS−/− female and HCT116 ASNS+/+ female mice (1.4-fold, q < 0.05) at 18 days post-implantation (Fig. 2C).